Research News and Research

RSS

Cost control issues take center stage in health care reform

Cost issues continue to receive attention as bipartisan support emerges on the Hill for a commission to control health care costs. Kaiser Health News reports:

11 Nov 2009

New microscope is expected to improve accuracy of intraoperative diagnostics

A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery.

11 Nov 2009

Adolescents less likely to wash hands and more susceptible to cross-contaminate raw foods while cooking

A Kansas State University study has shown that when preparing frozen foods, adolescents are less likely than adults to wash their hands and are more susceptible to cross-contaminating raw foods while cooking.

11 Nov 2009

Health overhaul proposals test limits of Democrats' unity

Politico reports that votes on a health care bill are subjecting some Democrats to fierce attacks - from other Democrats. "For some of 39 House Democrats who opposed the bill, there are protests outside their offices and promises of retribution.

11 Nov 2009

Health insurance industry profits examined

The characterization of the health insurance industry as high-profit is "a little mystifying" and "rather silly" given that their profit margins are thin compared to other industries, according to analysts interviewed by ABC News.

11 Nov 2009

Also in global health news: RUTF; global hunger; preventing natural disasters; El Salvador floods

"Rich nations should do more to help vulnerable countries prepare for natural disasters if they want their stretched humanitarian funds to go further during the economic downturn, a report said Tuesday," Reuters/New York Times reports

11 Nov 2009

Envoy Therapeutics secures loan from Takeda Research Investment

Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.

11 Nov 2009

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results as at and for the three-month and nine-month periods ended September 30, 2009.

11 Nov 2009

GeneNews discloses financial results for third-quarter 2009

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the third quarter-ended September 30, 2009.

11 Nov 2009

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund’s “Women of Action” awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

11 Nov 2009

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

The holidays should be a time when Americans focus on celebrating, reuniting with loved ones, enjoying holiday feasts and seemingly endless holiday treats. But, for the roughly 127 million Americans that struggle with maintaining healthy blood sugar and cholesterol levels, the stress of nearly two months of festivities can place enormous pressure on a body’s ability to maintain normal blood sugar and cholesterol levels.

11 Nov 2009

PRI's risk management conference focuses on public policy and future trends in medical malpractice

Physicians’ Reciprocal Insurers (PRI), the second largest medical malpractice insurer in New York state, today announced that it will host its Ninth Annual Risk Management Conference on Tuesday, November 17 at the Helmsley Hotel in New York City.

11 Nov 2009

Butterfly experiment in space

When NASA's space shuttle Atlantis launches for the International Space Station on Nov. 16 it will carry a University of Colorado at Boulder butterfly experiment that will be monitored by thousands of K-12 students across the nation.

11 Nov 2009

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

11 Nov 2009

Engineers develop technology to ensure "right first time" drug crystal formation in existing chemical reactors

Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.

11 Nov 2009

Report on the U.S. Government's drive for comparative effectiveness research

MarketResearch.com has announced the addition of GlobalData's new report "The US Government's Financial Support to Push Comparative Effectiveness Research," to their collection of Healthcare market reports.

11 Nov 2009

Cancer screening methods are not perfect: Experts

In a recent New York Times article, the American Cancer Society (ACS) ignited a major controversy over the benefits of cancer screening, specifically with regards to their breast and prostate cancer guidelines. In the article, Dr. Otis Brawley, chief medical officer of the ACS, responded to a study in the current issue of the Journal of the American Medical Association.

11 Nov 2009

Pfizer to close 6 R&D sites, lay off 2,000

Early Monday morning, the buzz at the International Society of Pharmaceutical Engineers (ISPE) conference in San Diego, California, was that Pfizer Incorporated was planning to sell its massive St. Louis/Chesterfield, Missouri, research site to Monsanto Company (St. Louis).

11 Nov 2009

Premier healthcare alliance expert's efforts to enhance patient safety receives recognition from DoD

The United States Department of Defense (DoD) has recognized a Premier healthcare alliance expert for his efforts to enhance patient safety while reducing healthcare costs.

11 Nov 2009

Prostate size growth not necessarily a predictor of development of cancer

New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.

11 Nov 2009